Novartis seeks European approval of cell therapy Kymriah – Reuters

ZURICH (Reuters) – Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer. Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern

and …read more

Coming Soon...